Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics
M. Crespo, M. Pascual, and N. Tolkoff-Rubin Acute humoral rejection in renal allograft recipients: incidence, serology and clinical characteristics Transplantation 71 2001 652
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection
P.N. Rocha, D.W. Butterly, and A. Greenberg Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection Transplantation 75 2003 1490
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection
P.N. Rocha, D.W. Butterly, and A. Greenberg Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection Transplantation 75 2003 1490
A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection
W.R. Mulley, F.J. Hudson, and B.D. Tait A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection Transplantation 87 2009 286
Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation
M. Ibernon, S. Gil-Bernet, and M. Carrera Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation Transplant Proc 37 2005 3743
Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients
Z. Csapo, C. Benavides-Viveros, and H. Podder Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients Transplant Proc 37 2005 2032